Basics Soleno Therapeutics, Inc. Common Stock Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. IPO Date: November 10, 2014 Sector: Healthcare Industry: Biotech Market Cap: $3.57B Activated in VL: True Average Daily Range Avg Daily Range: $0.43 | 3.65% Avg Daily Range (30 D): $1.87 | 3.09% Avg Daily Range (90 D): $1.85 | 2.61% Institutional Daily Volume Avg Daily Volume: .59M Avg Daily Volume (30 D): 1.75M Avg Daily Volume (90 D): 1.46M Trade Size Avg Trade Size (Sh.): 142 Avg Trade Size (Sh.) (30 D): 65 Avg Trade Size (Sh.) (90 D): 60 Institutional Trades Total Inst.Trades: 1,898 Avg Inst. Trade: $2.8M Avg Inst. Trade (30 D): $3M Avg Inst. Trade (90 D): $4.03M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $5.37M Avg Closing Trade (30 D): $11.94M Avg Closing Trade (90 D): $12.4M Avg Closing Volume: 93.08K     News Oct 22, 2025 @ 12:00 PM Cassava Sciences Appoints Dawn C. Bir to the Board... Source: Cassava Sciences, Inc. Oct 20, 2025 @ 10:46 PM SLNO Investor News: If You Have Suffered Losses in... Source: Rosen Law Firm Oct 15, 2025 @ 10:10 PM SLNO Investor News: If You Have Suffered Losses in... Source: Rosen Law Firm Oct 12, 2025 @ 9:09 PM SLNO Investor News: If You Have Suffered Losses in... Source: Rosen Law Firm Oct 6, 2025 @ 11:44 PM SLNO Investor News: If You Have Suffered Losses in... Source: Rosen Law Firm Financials   TTM Q2 2025 Q1 2025 Basic EPS $-4.13 $-.09 $-.95 Diluted EPS $-4.13 $-.09 $-.95 Revenue $ 32.66M $ 32.66M $ M Gross Profit $ $ 31.96M $ M Net Income / Loss $ -181.08M $ -4.71M $ -43.77M Operating Income / Loss $ -191.6M $ -6.53M $ -45.74M Cost of Revenue $ $ .7M $ M Net Cash Flow $ 19.47M $ -4.83M $ -6.6M PE Ratio     Splits Aug 26, 2022:   1:15 Oct 06, 2017:   1:5